| [1] |
Integrated Chinese and Western Medicine Ovarian Cancer Specialty Committee of China Anti-Cancer Association.
China expert consensus on diagnosis and treatment of low-grade serous ovarian cancer (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 11-20.
|
| [2] |
ZHANG Yuanfen, LONG Ying, YAO Desheng.
Relationship between perineural invasion,clinical pathological characteristics of cervical cancer and its effects on prognosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 109-114.
|
| [3] |
XUAN Wenzhen, GONG Jianmin, LI Na.
Incidence,mortality,and disease burden of cervical cancer in China,1990—2021: trends over the past 30 years and future prediction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 694-700.
|
| [4] |
LU Tingting, SHI Lijun, LIU Yingzhao, LIANG Huiting, WANG Qi.
Down⁃regulation of α2⁃macroglobulin expression activates TGF⁃β/SMADs signaling pathway to induce cisplatin resistance in ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 707-714.
|
| [5] |
Gynecological Oncology Group, the Invasive and Noninvasive Medical Committee of Chinese Medical Doctor Association, Reproductive Tract Disease Diagnosis and Treatment Branch of the China Healthy Birth Science Association, Oncofertility Branch of the China Healthy Birth Science Association.
Chinese consensus experts on diagnosis and treatment of uterine carcinosarcoma (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 385-391.
|
| [6] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
| [7] |
LONG Yuhao, ZHENG Bohao, ZHOU Shengtao.
Effect of m6A modification on ovarian cancer and its value as a potential therapeutic target
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 238-242.
|
| [8] |
XIAO Hui, QIN Hongen, YAO Ziyu, ZHOU Hui, MA Ronghe.
Paeoniflorin inhibiting the migration and invasion of endometrial cancer and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 623-630.
|
| [9] |
ZHANG Mengpei, YIN Rutie.
Epithelial ovarian cancer: current status and progress of chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 477-484.
|
| [10] |
LIU Zhiming, JIANG Jie.
Chemotherapy for advanced or recurrent endometrial cancer: progress,status and challenges
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 485-491.
|
| [11] |
WU Daying, JIANG Yao, LI Guiling .
Progress of chemotherapy for cervical cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 492-498.
|
| [12] |
LIU Linying, GUO Ciren, SUN Yang.
Progress of chemotherapy for vaginal malignant tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 499-503.
|
| [13] |
LIU Chuan, LI Xiuqin .
Chemotherapy of uterine sarcoma and its prospect
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 504-509.
|
| [14] |
TAN Yue, LU Xin.
Progress of drug treatment for vulvar cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 510-515.
|
| [15] |
HUANG Chuntao, WEN Tianbin, LYU Sihui, LIANG Jinlan, WANG Qi.
Construction and validation of a prognostic model for cervical cancer based on tumor immune cycle-related genes
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 398-405.
|
